Albert Parés

1985–2025 年に発表

別表記
Albert Pares
112
論文数
19,186
被引用数
77
h 指数
109
i10 指数

被引用数

Albert Parés の年別被引用数1987 年: 被引用 5 件1988 年: 被引用 2 件1989 年: 被引用 2 件1990 年: 被引用 5 件1991 年: 被引用 5 件1992 年: 被引用 14 件1993 年: 被引用 17 件1994 年: 被引用 15 件1995 年: 被引用 21 件1996 年: 被引用 14 件1997 年: 被引用 20 件1998 年: 被引用 26 件1999 年: 被引用 25 件2000 年: 被引用 47 件2001 年: 被引用 59 件2002 年: 被引用 63 件2003 年: 被引用 79 件2004 年: 被引用 54 件2005 年: 被引用 80 件2006 年: 被引用 62 件2007 年: 被引用 83 件2008 年: 被引用 91 件2009 年: 被引用 82 件2010 年: 被引用 99 件2011 年: 被引用 80 件2012 年: 被引用 68 件2013 年: 被引用 112 件2014 年: 被引用 76 件2015 年: 被引用 174 件2016 年: 被引用 76 件2017 年: 被引用 169 件2018 年: 被引用 162 件2019 年: 被引用 539 件2020 年: 被引用 578 件2021 年: 被引用 580 件2022 年: 被引用 647 件2023 年: 被引用 547 件2024 年: 被引用 906 件2025 年: 被引用 449 件2026 年: 被引用 19 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,379 件、この内訳の 18.3%イギリス: 引用元論文 659 件、この内訳の 8.7%イタリア: 引用元論文 523 件、この内訳の 6.9%中国: 引用元論文 518 件、この内訳の 6.9%ドイツ: 引用元論文 495 件、この内訳の 6.6%スペイン: 引用元論文 422 件、この内訳の 5.6%カナダ: 引用元論文 345 件、この内訳の 4.6%フランス: 引用元論文 297 件、この内訳の 3.9%オランダ: 引用元論文 271 件、この内訳の 3.6%日本: 引用元論文 183 件、この内訳の 2.4%スイス: 引用元論文 155 件、この内訳の 2.1%ベルギー: 引用元論文 152 件、この内訳の 2%
0%18.3%その他 28.4%

分野

  • Medicine86.2%
  • Biochemistry, Genetics and Molecular Biology7.1%
  • Pharmacology, Toxicology and Pharmaceutics2.8%
  • Immunology and Microbiology1.6%
  • Nursing0.8%
  • Engineering0.2%
  • その他1.3%

トピック

  • Liver Disease Diagnosis and Treatment15.5%
  • Liver Diseases and Immunity13.3%
  • Liver Disease and Transplantation7.6%
  • Pediatric Hepatobiliary Diseases and Treatments4.6%
  • Drug Transport and Resistance Mechanisms4.4%
  • Gallbladder and Bile Duct Disorders3.1%
  • その他51.5%

共著者

全論文

検索で開く
  1. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Y Simonova, Albert Pares, Philip Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T Ma, Juan M Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez-Pinto, Deirdre Kelly, Robyn Burton, Jeffrey V Lazarus, Pere Ginès, Maria Buti, Philip N Newsome, Patrizia Burra, Michael P Manns - The Lancet 2021 被引用: 627

  2. EASL Clinical Practice Guidelines on nutrition in chronic liver disease

    著者: , , , , , , , - Journal of Hepatology 2018 被引用: 1,055

  3. Simplified criteria for the diagnosis of autoimmune hepatitis†

    著者: , , , , , , , , , , , , , , , , , - Hepatology 2008 被引用: 1,882

  4. openalex_id:w4200584065

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Simonova, Albert Parés, Philip J. Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T., Juan Manuel Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez‐Pinto, Déirdre Kelly, Robyn Burton, Jeffrey V. Lazarus, Pere Ginès, Marı́a Buti, Philip N. Newsome, Patrizia Burra, Michael P. Manns 被引用: 245

  5. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine N. Manser, George Ν. Dalekos, Bertus Eksteen, Pietro Invernizzi, Christoph P. Berg, Gabi I. Kirchner, Christoph Sarrazin, Vincent Zimmer, Luca Fabris, Felix Braun, Marco Marzioni, Brian D. Juran, Karouk Said, Christian Rupp, Kalle Jokelainen, M Valle, Francesca Saffioti, Angela Cheung, Michael Trauner, Christoph Schramm, Roger W. Chapman, Tom H. Karlsen, Erik Schrumpf, Christian P. Strassburg, Michael P. Manns, Keith D. Lindor, Gideon M. Hirschfield, Bettina E. Hansen, Kirsten Muri Boberg - Gastroenterology 2017 被引用: 523

  6. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial

    著者: , , , , , , , , , , , , , , , - Gastroenterology 2020 被引用: 210

  7. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ulrich Beuers, Rinse K. Weersma, Cisca Wijmenga, Hanns–Ulrich Marschall, Piotr Milkiewicz, Albert Parés, Kimmo Kontula, Olivier Chazouillères, Pietro Invernizzi, Elizabeth C. Goode, Kelly Spiess, Carmel Moore, Jennifer Sambrook, Willem H. Ouwehand, David J. Roberts, John Danesh, Annarosa Floreani, Aliya Gulamhusein, John E. Eaton, Stefan Schreiber, Catalina Coltescu, Christopher L. Bowlus, Velimir A. Luketic, Joseph A. Odin, Kapil Chopra, Kris V. Kowdley, Naga Chalasani, Michael P. Manns, Brijesh Srivastava, George Mells, Richard Sandford, Graeme Alexander, Daniel J. Gaffney, Roger W. Chapman, Gideon M. Hirschfield, Mariza de Andrade, Simon Rushbrook, André Franke, Tom H. Karlsen, Konstantinos N. Lazaridis, Carl A. Anderson - Nature Genetics 2016 被引用: 382

  8. A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA

    著者: , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 被引用: 178

  9. Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2014 被引用: 489

  10. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2015 被引用: 436

  11. Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid

    著者: , , , , , , , , , , , , , , , , , - Gastroenterology 2014 被引用: 565

  12. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

    著者: , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2019 被引用: 277

  13. A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis

    著者: , , , , , , , , , , , , , , , , , , - Hepatology 2017 被引用: 277

  14. Excellent Long-Term Survival in Patients With Primary Biliary Cirrhosis and Biochemical Response to Ursodeoxycholic Acid

    著者: , , - Gastroenterology 2006 被引用: 758

  15. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel Smith, Steve Flack, Victoria Mulcahy, Michael Trauner, Christopher L. Bowlus, Keith D. Lindor, Christophe Corpechot, David Jones, George Mells, Gideon M. Hirschfield, James Wason, Bettina E. Hansen, Richard Sturgess, Christopher G. Healey, Anton Gunasekera, Yiannis Kallis, Gavin Wright, Thiriloganathan Mathialahan, Richard J. Evans, Jaber Gasem, David Ramanaden, Emma Ward, Mahesh Bhalme, Paul Southern, James L. Maggs, Mohamed Yousif, George Mells, Brijesh Srivastava, Matthew Foxton, Carole Collins, Yash Prasad, Francisco Porras-Perez, Tom Yapp, Minesh Patel, Roland Ede, Martyn Carte, Konrad Koss, Prayman Sattianayagam, Charles Grimley, Jude Tidbury, Dina Mansour, Matilda Beckley, Coral Hollywood, John Ramag, Harriet Gordon, Joanne Ridpath, Bob Grover, George Abouda, Ian Rees, Mark Narain, Imroz Salam, Paul Banim, Debasish Das, Helen Matthews, Faiyaz Mohammed, Rebecca Jones, Sambit Sen, G. W. G. Bird, Martin Prince, Geeta Prasad, Paul Kitchen, John Hutchinson, Prakash C. Gupta, David Jones, Amir Shah, Subrata Saha, Katharine Pollock, Stephen Barclay, Natasha McDonald, Simon Rushbrook ほか 56 名 - Gastroenterology 2022 被引用: 101

  16. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vilas Patwardhan, Cristina Rigamonti, Marco Carbone, Pietro Invernizzi, Laura Cristoferi, Adriaan van der Meer, Rozanne de Veer, Ehud Zigmond, Eyal Yehezkel, Andreas E. Kremer, Ansgar Deibel, Jérôme Dumortier, Tony Bruns, Karsten Große, Georges‐Philippe Pageaux, Aaron Wetten, Jessica Dyson, David G. Jones, Olivier Chazouillères, Bettina Hansen, Victor de Lédinghen - Journal of Hepatology 2022 被引用: 116

  17. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joost P.H. Drenth, Jessica Dyson, Cumali Efe, Bastian Engel, S. Ferri, R Fontana, Nikolaos Gatselis, Alessio Gerussi, Emina Halilbasic, Neil Halliday, Michael A. Heneghan, Gideon M. Hirschfield, Bart van Hoek, Marianne Hørby Jørgensen, G. Indolfini, Raffaele Iorio, Soo Jeong, D. Jones, Déirdre Kelly, Nanda Kerkar, Florence Lacaille, Craig Lammert, B. Leggett, Marco Lenzi, C Levy, Rodrigo Liberal, Ana Lleò, Ansgar W. Lohse, Susana López, Eléonora De Martin, Valérie A. McLin, Giorgina Mieli‐Vergani, Piotr Milkiewicz, Nitesh Mohan, Luigi Muratori, Gabriella Nebbia, C. van Nieuwkerk, Ye Htun Oo, Alberto Ortega, Albert Parés, Tudor Lucian Pop, Daniel S. Pratt, Tuğrul Pürnak, Giusy Ranucci, Simon Rushbrook, Christoph Schramm, Albert Friedrich Stättermayer, Mark G. Swain, Atsushi Tanaka, Richard Taubert, Débora Raquel Benedita Terrabuio, B. Terziroli, Michael Trauner, Pamela L. Valentino, F. van den Brand, A. Villamil, Staffan Wåhlin, Henriette Ytting, Kalliopi Zachou, Mikio Zeniya - Journal of Hepatology 2022 被引用: 173

  18. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Gastroenterology 2020 被引用: 171

  19. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2012 被引用: 561

  20. Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2019 被引用: 116

  21. A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA

    著者: , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 105

  22. Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adèle Delamarre, Natalia Sobenko, Alejandra Villamil, Esli Medina‐Morales, Alan Bonder, Vilas Patwardhan, Cristina Rigamonti, Marco Carbone, Pietro Invernizzi, Laura Cristoferi, Adriaan van der Meer, Rozanne de Veer, Ehud Zigmond, Eyal Yehezkel, Andreas E. Kremer, Ansgar Deibel, Tony Bruns, Karsten Große, Aaron Wetten, Jessica Dyson, David Jones, Jérôme Dumortier, Georges‐Philippe Pageaux, Victor de Lédinghen, Olivier Chazouillères, Fabrice Carrat, the Global & ERN Rare-Liver PBC Study Groups - Hepatology 2023 被引用: 78

  23. Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult‐to‐treat primary biliary cholangitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2021 被引用: 74

  24. Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2018 被引用: 127